Natixis’s STAAR Surgical STAA Stock Holding History

Natixis’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-13,900	Closed	-$731K	–	1132
2023 Q2	$731K	Buy	+13,900	New	+$846K	0.01%	592

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

AIM

Anatole Investment Management Central, Hong Kong $716M AUM 502.49% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Natixis's STAA Position: Q3 2023 in Review

Natixis sold out of STAAR Surgical (STAA) in Q3 2023, closing a stake of 13,900 shares — an estimated $731K sold.

Natixis first reported a position in STAA in Q2 2023 and held it in 1 quarter. The position peaked at $731K in Q2 2023. 217 funds tracked by Wall St. Rank hold STAA as of Q3 2023.

Natixis reported no remaining STAAR Surgical position as of Q3 2023 after selling out during the quarter.
Natixis sold 13,900 STAAR Surgical shares in Q3 2023, an estimated $731K.
Natixis first reported a position in STAAR Surgical in Q2 2023 and held it in 1 quarter.
Natixis's STAAR Surgical position peaked at $731K in Q2 2023.
217 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2023.

Based on Natixis's 13F filing for Q3 2023, filed 14 Nov 2023.